CANKADO   Report issue

For profit Phase 2 Phase 4
Founded: Munich Germany (2015)
Status: No NME R&D (2015)

Organization Overview

First Clinical Trial
2017
NCT03220178
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

CANKADO